MENU

Can Oddity Tech (ODD) Stock Reach $30?

A.I.Advisor
published price charts
A.I.Advisor
Nov 11, 2026

Can Oddity Tech (ODD) Stock Reach $30?

Key Takeaways

  • The $30 price objective used here is not an analyst consensus; it is the highest single price target on the Street, from KeyBanc, and is applied because the broader analyst average sits below the current share price.
  • Oddity Tech Ltd. (ODD) trades around $19.90, meaning a move to $30 would require a gain of roughly 51%, a very large advance.
  • The published analyst range is unusually wide, from about $8 to $30, with most targets clustering between $15 and $19 and a mean near $16–$17.
  • Supportive factors include a stabilizing revenue trend, an earnings beat, growth at SpoiledChild and METHODIQ, and aggressive buybacks.
  • Principal risks are the unresolved IL MAKIAGE advertising disruption, margin compression, and a consensus that still implies downside.
  • You can explore Major News, Today's Price Move, the Forecast, and Earnings pages for additional detail on this ticker.
  • Explore Trending AI Robots to see how AI-driven tools are being applied to market monitoring.

Analyst Price Targets and Consensus View

Oddity Tech Ltd. (ODD) is a consumer-technology company that builds digital-first beauty and wellness brands, chiefly IL MAKIAGE and SpoiledChild, alongside the newer METHODIQ telehealth brand. It is a stock, not an exchange-traded fund. Its analyst picture is unusually lopsided: the prevailing consensus rating is Hold, and the average twelve-month price target sits near $16–$17, below the current share price of about $19.90.

Because the aggregate analyst target is below the market price, it cannot serve as a meaningful upside objective. The $30 figure instead comes from public, identifiable research: KeyBanc's Buy-rated price target, the highest on the Street. For context, the full range runs from roughly $8 (Goldman Sachs and Barclays) to $30, with recent actions including Morgan Stanley's $18.50 target (October 2026), J.P. Morgan's $18 reinstatement, Truist and Jefferies at $18, and Bank of America at $10. Analysts disagree sharply because the debate is whether 2026's contraction was temporary or structural.

Current Market Position and Path Toward the Target

With shares near $19.90, reaching $30 would require an increase of approximately 51%, a very large move. The stock's 52-week range is wide, from about $9.25 to $46.45, reflecting a steep drawdown followed by a partial recovery. Third-quarter results, reported in November 2026, showed adjusted earnings per share (EPS) of $0.37 versus a $0.30 consensus, while revenue of roughly $145 million declined only 2% year over year, a sharp improvement from declines of about 25% in the prior two quarters.

The path toward a higher price would likely require sustained revenue inflection, resolution of the IL MAKIAGE advertising-account dislocation, and a recovery in margins that compressed to 67.4% gross margin from 71.6% a year earlier. A return toward $30 would also require the market to re-rate the stock after its forward P/E (price-to-earnings) multiple reset from earlier elevated levels.

What Could Support a Move Toward the Target

  • Revenue stabilization, with third-quarter declines narrowing to 2% and management guiding full-year 2026 revenue down only about 18.5% versus a prior 19%.
  • SpoiledChild is on track to approach $350 million in 2026 revenue, growth of at least 35%, while METHODIQ is expected to exceed SpoiledChild's first-year revenue.
  • A 2027 recovery narrative, with analysts modeling revenue growth of roughly 14% and a rebound in EPS next year.
  • Aggressive capital returns: the company repurchased about $163 million of stock in the first nine months of 2026, reducing the share count by roughly 20%.

What Could Prevent the Target From Being Reached

  • The IL MAKIAGE ad-account dislocation with its largest advertising partner remains unresolved after multiple quarters, pressuring customer-acquisition costs and first-order growth.
  • Profitability deterioration: adjusted net income and adjusted EBITDA have fallen sharply year over year, and free cash flow has thinned to roughly breakeven.
  • The analyst consensus itself implies downside, with several Sell or Underweight ratings and a mean target below the market price.
  • Macroeconomic softness and competition in beauty and wellness could prolong the recovery or pressure valuation multiples further.

Technical Levels and Market Structure

The stock has recovered substantially from its 52-week low near $9.25 but remains well below its 52-week high near $46.45. Shares have been trading through the high-teens and low-$20s, making the $20 psychological level a nearby reference point. A durable move toward $30 would first need to clear prior resistance in the low-to-mid-$20s before approaching higher zones established earlier in the year. The wide trading range and a beta above 2.0 underscore the stock's elevated volatility.

Time Horizon and What Investors Should Monitor

Analyst price targets typically reflect a roughly twelve-month research horizon, though KeyBanc's $30 target was established earlier in 2026 and may reflect a longer recovery path. Investors should watch for evidence that the IL MAKIAGE advertising issue is resolving, customer-acquisition-cost trends, SpoiledChild and METHODIQ growth, fourth-quarter guidance, and any analyst target revisions following the latest earnings. Margin recovery and free-cash-flow generation are also key signposts toward a sustainable re-rating.

AI Daily Buy/Sell Signals

Tickeron's AI Daily Buy/Sell Signals use artificial intelligence to continuously monitor thousands of stocks and ETFs, generating Buy, Sell, or Hold signals as market conditions, technical behavior, and AI-driven analysis evolve. Traders can use the tool to surface opportunities, keep an eye on existing positions, and detect changing trends more efficiently than manual screening allows. For those following volatile names like ODD, automated signal monitoring can help identify shifts in momentum as they develop.

Final Assessment

The $30 level for ODD is not a consensus forecast; it is the highest single analyst price target, from KeyBanc, and would require a gain of about 51% from current levels. Supportive factors include stabilizing revenue, an earnings beat, and momentum in newer brands, but the unresolved IL MAKIAGE issue, margin erosion, and a consensus that still implies downside are substantial obstacles. The wide $8-to-$30 analyst range reflects genuine disagreement about the durability of the recovery, and no outcome should be treated as certain. Investors should monitor advertising-cost normalization, brand-level growth, and upcoming guidance before drawing conclusions.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

View a ticker or compare two or three
Interact to see
Advertisement

ODD and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ODD has been loosely correlated with ALIT. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if ODD jumps, then ALIT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ODD
1D Price
Change %
ODD100%
+5.38%
ALIT - ODD
37%
Loosely correlated
+5.67%
RBRK - ODD
37%
Loosely correlated
-0.45%
CPAY - ODD
37%
Loosely correlated
+1.36%
ZS - ODD
37%
Loosely correlated
-0.39%
TOST - ODD
33%
Loosely correlated
+3.46%
More

Groups containing ODD

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ODD
1D Price
Change %
ODD100%
+5.38%
Household/Personal Care
industry (30 stocks)
25%
Poorly correlated
+2.55%
Consumer Non Durables
industry (179 stocks)
11%
Poorly correlated
+0.20%
Can Oddity Tech (ODD) Stock Reach $30?